フリバンセリンの評価:FDAの科学と擁護
Walid F Gellad1, Kathryn E Flynn2, G Caleb Alexander3
1Division of General Internal Medicine and Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania2Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
JAMA
|July 7, 2015
まとめ
No abstract available in PubMed .
